Literature DB >> 12204561

Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles.

Wusheng Yin1, Emmanuel O Akala, Robert E Taylor.   

Abstract

A hydrolyzable crosslinker (N,O-dimethacryloylhydroxylamine (MANHOMA)) was synthesized by a modified method and was characterized using 1H-NMR, FTIR, and melting point determination. Naltrexone-loaded nanoparticles were prepared by copolymerization of poly(ethylene glycol)1000 monomethyl ether mono methacrylate (PEO-MA), methyl methacrylate (MMA) and N,O-dimethacryloylhydroxylamine (MANHOMA) in 0.4% poly(vinyl alcohol) aqueous solution. The nanoparticles were characterized by FTIR, particle size determination and transmission electron microscope (TEM). The TEM photomicrographs of the nanoparticles show a crosslinked core surrounded by a ring formed by the polyethylene glycol tail of PEO-MA. The loading efficiency of the nanoparticles and in vitro drug availability from the nanoparticles were investigated. The naltrexone-loaded hydrolyzable crosslinked nanoparticles were able to sustain the release of naltrexone for different periods of time, depending on the monomer feed composition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204561      PMCID: PMC2925203          DOI: 10.1016/s0378-5173(02)00297-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

Review 1.  Drug therapy for alcohol dependence.

Authors:  R M Swift
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

2.  Polymerized micelles and their use as adjuvants in immunology.

Authors:  G Birrenbach; P P Speiser
Journal:  J Pharm Sci       Date:  1976-12       Impact factor: 3.534

Review 3.  Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.

Authors:  H R Kranzler
Journal:  Alcohol Alcohol       Date:  2000 Nov-Dec       Impact factor: 2.826

4.  Novel pH-sensitive hydrogels with adjustable swelling kinetics.

Authors:  E O Akala; P Kopecková; J Kopecek
Journal:  Biomaterials       Date:  1998-06       Impact factor: 12.479

5.  Submicrometer Particle Sizing by Multiangle Light Scattering following Fractionation

Authors: 
Journal:  J Colloid Interface Sci       Date:  1998-01-01       Impact factor: 8.128

Review 6.  Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.

Authors:  R Z Litten; J Allen; J Fertig
Journal:  Alcohol Clin Exp Res       Date:  1996-08       Impact factor: 3.455

Review 7.  Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.

Authors:  D A Johnson
Journal:  J Clin Psychiatry       Date:  1984-05       Impact factor: 4.384

8.  Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818.

Authors:  C Allen; Y Yu; D Maysinger; A Eisenberg
Journal:  Bioconjug Chem       Date:  1998 Sep-Oct       Impact factor: 4.774

9.  Giant wormlike rubber micelles

Authors: 
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

Review 10.  Alcoholism treatment in the United States. An overview.

Authors:  R K Fuller; S Hiller-Sturmhöfel
Journal:  Alcohol Res Health       Date:  1999
View more
  11 in total

1.  Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.

Authors:  Emmamuel O Akala; Pornruedee Wiriyacoonkasem; Gaofeng Pan
Journal:  Drug Dev Ind Pharm       Date:  2011-03-30       Impact factor: 3.225

2.  Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA.

Authors:  Elham Khodaverdi; Farnaz Sadat Mirzazadeh Tekie; Seyed Ahmad Mohajeri; Fariba Ganji; Gholamhossein Zohuri; Farzin Hadizadeh
Journal:  AAPS PharmSciTech       Date:  2012-04-18       Impact factor: 3.246

3.  Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies.

Authors:  Simeon K Adesina; Alesia Holly; Gabriela Kramer-Marek; Jacek Capala; Emmanuel O Akala
Journal:  J Pharm Sci       Date:  2014-06-24       Impact factor: 3.534

4.  Disposition of naltrexone after intravenous bolus administration in Wistar rats, low-alcohol-drinking rats and high-alcohol-drinking rats.

Authors:  Emmanuel O Akala; Hu Wang; Adedayo Adedoyin
Journal:  Neuropsychobiology       Date:  2008-10-03       Impact factor: 2.328

Review 5.  Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.

Authors:  Simeon K Adesina; Emmanuel O Akala
Journal:  Mol Pharm       Date:  2015-11-09       Impact factor: 4.939

6.  MS-Monitored Conjugation of Poly(ethylene glycol) Monomethacrylate to RGD Peptides.

Authors:  Oleg I Bol'shakov; Emmanuel O Akala
Journal:  J Appl Polym Sci Symp       Date:  2014-07-15

7.  Opioid Antagonist Nanodrugs Successfully Attenuate the Severity of Ischemic Stroke.

Authors:  Nadia Peyravian; Enze Sun; Emre Dikici; Sapna Deo; Sylvia Daunert; Michal Toborek
Journal:  Mol Pharm       Date:  2022-05-04       Impact factor: 5.364

8.  Antiretroviral Drugs-Loaded Nanoparticles Fabricated by Dispersion Polymerization with Potential for HIV/AIDS Treatment.

Authors:  Oluwaseun Ogunwuyi; Namita Kumari; Kahli A Smith; Oleg Bolshakov; Simeon Adesina; Ayele Gugssa; Winston A Anderson; Sergei Nekhai; Emmanuel O Akala
Journal:  Infect Dis (Auckl)       Date:  2016-03-20

9.  Cellular uptake and cytotoxicity studies of pH-responsive polymeric nanoparticles fabricated by dispersion polymerization.

Authors:  Reema Puri; Simeon Adesina; Emmanuel Akala
Journal:  J Nanosci Nanomed       Date:  2018-04-12

10.  Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound.

Authors:  Kahli A Smith; Xionghao Lin; Oleg Bolshakov; James Griffin; Xiaomei Niu; Dmytro Kovalskyy; Andrey Ivanov; Marina Jerebtsova; Robert E Taylor; Emmanuel Akala; Sergei Nekhai
Journal:  Sci Pharm       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.